drugset / Trial / NCT01952444
Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers
RandomizedParallel-groupOpen-labelOther
Summary
Evaluate the safety, tolerability and pharmacokinetics (PK) of intravenous (IV) ETI-204 alone and in the presence of IV and oral ciprofloxacin
Timeline
- Start
- 2013-10-29
- Primary completion
- 2014-04-09
- Completion
- 2014-04-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ciprofloxacin | Small molecule | 750 mg | Intravenous |
| Subject | Obiltoxaximab | Monoclonal antibody | 16 mg/kg | Intravenous |